Evidence map›Paper›PMID 23288871›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2013

A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine.

Margaret S Chisolm, Heather Fitzsimons, Jeannie-Marie S Leoutsakos, Shauna P Acquavita, Sarah H Heil, Molly Wilson-Murphy, Michelle Tuten, Karol Kaltenbach, Peter R Martin, Bernadette Winklbaur and 2 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Maintenance agonist treatments for opiate-dependent pregnant women.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Interventions to reduce harm from continued tobacco use.The Cochrane database of systematic reviews · 2016
    Pooled it
  3. Pooled it
  4. Trial
  5. Cigarette Smoking Cessation Intervention for Buprenorphine Treatment Patients.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2018
    Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Rates of substance and polysubstance use through universal maternal testing at the time of delivery.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  17. Morphine Exposure Reduces Nicotine-Induced Upregulation of Nicotinic Receptors and Decreases Volitional Nicotine Intake in a Mouse Model.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Margaret S ChisolmDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA. mchisol1@jhmi.edu
Heather Fitzsimons
Jeannie-Marie S Leoutsakos
Shauna P Acquavita
Sarah H Heil
Molly Wilson-Murphy
Michelle Tuten
Karol Kaltenbach
Peter R Martin
Bernadette Winklbaur
Lauren M Jansson
Hendrée E Jones

Funding

YOHIMBINE AS A MODEL OF ORTHOSTATIC INTOLERANCEM01RR000095 · NCRR · VANDERBILT UNIVERSITY · PI DRAKE, WONDER P. · 1985 to 2008
$38.3M
Maternal Opioid Treatment: Human Experimental ResearchR01DA015738 · NIDA · THOMAS JEFFERSON UNIVERSITY · PI KALTENBACH, KAROL A · 2004 to 2008
$3.6M
Fetal and Infant Neurobehavioral Effects of Maternal Buprenorphine TreatmentR01DA031689 · NIDA · JOHNS HOPKINS UNIVERSITY · PI JANSSON, LAUREN M · 2011 to 2015
$2.7M
Maternal Opioid Treatment: Human Experimental ResearchR01DA015832 · NIDA · WAYNE STATE UNIVERSITY · PI STINE, SUSAN M · 2004 to 2009
$2.2M
Maternal Opioid Treatment: Human Experimental ResearchR01DA018410 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HEIL, SARAH H · 2004 to 2008
$2.2M
Maternal Opioid Treatment: Human ExperimentalR01DA018417 · NIDA · MEDICAL UNIVERSITY OF VIENNA · PI FISCHER, GABRIELE · 2004 to 2008
$1.8M
Maternal Opioid Treatment: Human Experimental ResearchR01DA015778 · NIDA · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI LESTER, BARRY M. · 2004 to 2009
$1.6M
Maternal Opioid Treatment: Human Experimental ResearchR01DA015741 · NIDA · ST. JOSEPH'S HEALTH CENTRE · PI SELBY, PETER L · 2004 to 2008
$643k
NCRR NIH HHS M01 RR00095NCRR NIH HHS M01 RR109NIDA NIH HHS R01 DA015738NIDA NIH HHS R01 DA015741NIDA NIH HHS R01 DA015778NIDA NIH HHS R01 DA017513NIDA NIH HHS R01 DA018410NIDA NIH HHS R01 DA018417NIDA NIH HHS R01 DA15832
6 · The paper itself

Abstract

introductionLittle is known about the relationship between cigarette smoking and agonist treatment in opioid-dependent pregnant patients. The objective of this study is to examine the extent to which cigarette smoking profiles differentially changed during the course of pregnancy in opioid-dependent patients receiving either double-blind methadone or buprenorphine. Patients were participants in the international, randomized controlled Maternal Opioid Treatment: Human Experimental Research (MOTHER) study.

methodsA sample of opioid-maintained pregnant patients (18-41 years old) with available smoking data who completed a multisite, double-blind, double-dummy, randomized controlled trial of methadone (n = 67) and buprenorphine (n = 57) between 2005 and 2008. Participants were compared on smoking variables based on opioid agonist treatment condition.

resultsOverall, 95% of the sample reported cigarette smoking at treatment entry. Participants in the two medication conditions were similar on pretreatment characteristics including smoking rates and daily cigarette amounts. Over the course of the pregnancy, no meaningful changes in cigarette smoking were observed for either medication condition. The fitted difference in change in adjusted cigarettes per day between the two conditions was small and nonsignificant (β = -0.08, SE = 0.05, p = .132).

conclusionsResults support high rates of smoking with little change during pregnancy among opioid-dependent patients, regardless of the type of agonist medication received. These findings are consistent with evidence that suggests nicotine effects, and interactions may be similar for buprenorphine compared with methadone. The outcomes further highlight that aggressive efforts are needed to reduce/eliminate smoking in opioid-dependent pregnant women.

Indexed as

AdolescentAdultBuprenorphineFemaleHumansMethadoneOpiate Substitution TreatmentOpioid-Related DisordersPregnancySmokingYoung AdultBuprenorphineMethadone

Identifiers

PMID23288871
PMCPMC3682847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.